Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

NET 16Gastrointestinal 16Endocrine 16Thoracic 1Dermatologic 1Breast 1

Conditions

Lung Neoplasms 1370Carcinoma, Non-Small-Cell Lung 1080Breast Neoplasms 183Neoplasms 145Small Cell Lung Carcinoma 137Colorectal Neoplasms 104Adenocarcinoma of Lung 86Melanoma 84Prostatic Neoplasms 80Pancreatic Neoplasms 79Esophageal Neoplasms 70Head and Neck Neoplasms 69Ovarian Neoplasms 67Colonic Neoplasms 67Stomach Neoplasms 63Urinary Bladder Neoplasms 49Neoplasm Metastasis 49Disease 49Mesothelioma 44Liver Neoplasms 44Pulmonary Disease, Chronic Obstructive 42Mesothelioma, Malignant 42Brain Neoplasms 37Lung Diseases 36Carcinoma, Renal Cell 35Uterine Cervical Neoplasms 34Pleural Effusion, Malignant 34Kidney Neoplasms 33NSCLC 31Carcinoma 28

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Gastro-enteropancreatic neuroendocrine tumor × Thoracic × Clear all
NCT02948946 2021-08-04

Clinical Utility Assay as a Biomarker for Gastroenteropancreatic and Lung Neuroendocrine Tumors

H. Lee Moffitt Cancer Center and Research Institute

Completed
105 enrolled
EndocrineGastrointestinalNETThoracic

Gastro-enteropancreatic neuroendocrine tumor, Lung Neoplasms, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡